CORRECTING and REPLACING JSR Expands Bioprocess Offerings Through Strategic Investment and Commercial Partnership with Natrix

  CORRECTING and REPLACING JSR Expands Bioprocess Offerings Through Strategic
  Investment and Commercial Partnership with Natrix Separations

CORRECTION...by JSR Life Sciences

Business Wire

SUNNYVALE, Calif. -- September 10, 2013

Please replace the release with the following corrected version due to
multiple revisions in the headline and body.

The corrected release reads:

 JSR EXPANDS BIOPROCESS OFFERINGS THROUGH STRATEGIC INVESTMENT AND COMMERCIAL
                     PARTNERSHIP WITH NATRIX SEPARATIONS

JSR Corporation (President: Mitsunobu Koshiba) announced today that it has
expanded its Life Sciences initiative with a strategic investment in Natrix
Separations, the developer of Natrix™ HD Membrane Technology and Advective™
Chromatography. The companies have also entered into a global distribution
agreement for commercialization of Natrix bioprocess products with execution
by regional JSR Life Sciences teams based at JSR group companies, JSR Micro,
Inc., JSR Micro N.V. and JSR Life Sciences Corporation in Japan.

Natrix™ HD Membrane Technology and Advective™ Chromatography is available in
NatriFlo™ flow-through chromatography products for biomolecule polish
applications and complements JSR’s existing bioprocess technology including
its Amsphere™ Protein A media for monoclonal antibody purification, which the
company successfully launched last year.

“We are very pleased to enter into this partnership with Natrix,” said Nobu
Koshiba, president of JSR Corporation. “Over the past decade, Natrix has
developed and proven its proprietary technology, which is now ready for
industry adoption. The Natrix platform combines with our existing product
lines to enable JSR to offer a complete downstream tool set for the bioprocess
industry.”

Natrix™HD Membrane Technology combines binding capacity that exceeds
conventional resin-based columns and fast flow-rates typical of membrane
adsorbers. The versatile technology can be deployed in flow-through or
bind-elute mode. Natrix will launch its NatriFlo™ flow-through product line
for polish applications in September. NatriFlo delivers best-in-class HCP
removal, DNA removal and Viral Clearance, even with the most challenging
feedstreams, and with plenty of capacity to spare. Natrix will launch its
NatriPur™ bind-elute chromatography products in 2014.

“Natrix technology enables biomolecule developers and manufacturers to achieve
a new level of low-cost, highly flexible productivity in their purification
operations. We are excited to partner with JSR Life Sciences to bring these
products to market,” said John Chickosky, Natrix Separations President & CEO.
“Already, customers around the world have expressed great interest in
simplifying and adding flexibility to their downstream operations with Natrix
technology, and JSR’s global presence and strength makes them a perfect
partner to serve those customers.”

About JSR Life Sciences

JSR Life Sciences Corporation (JLS) has set out for a unique life sciences
company which continuously provides outstanding materials and applications for
customers in life science and medical industries. Our products are based on
prominent material technologies cultivated for a long time in JSR and
incorporated with state-of-the-art technologies acquired through our global
network.

About Natrix Separations

Natrix Separations, based in Burlington, Ontario, Canada, is the developer of
Natrix™ HD Membrane Technology for the purification of biopharmaceuticals.
Natrix™HD Membrane Technology combines binding capacity that exceeds
conventional resin-based chromatography columns and fast flow-rates typical of
membrane adsorbers for both flow-through and bind-elute capture applications.
Natrix products enable biopharmaceutical manufacturers with a complete set of
purification tools that overcome the efficiency, speed, and flexibility
barriers imposed by conventional capital-intensive approaches to
chromatography. Natrix products feature well-established industry-standard
chemistries and are scalable from R&D to commercial manufacturing.

Contact:

JSR Life Sciences
Missy Bindseil, 408-543-8945
mbindseil@jsrmicro.com
or
Natrix Separations
Molly McGlaughlin, 617-548-7927
mcglaughlin@natrixseparations.com